KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Aquestive Therapeutics (AQST) Assets Average: 2018-2024

Historic Assets Average for Aquestive Therapeutics (AQST) over the last 7 years, with Dec 2024 value amounting to $79.4 million.

  • Aquestive Therapeutics' Assets Average rose 13.05% to $128.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $128.6 million, marking a year-over-year increase of 13.05%. This contributed to the annual value of $79.4 million for FY2024, which is 38.74% up from last year.
  • Aquestive Therapeutics' Assets Average amounted to $79.4 million in FY2024, which was up 38.74% from $57.2 million recorded in FY2023.
  • In the past 5 years, Aquestive Therapeutics' Assets Average ranged from a high of $79.4 million in FY2024 and a low of $57.2 million during FY2023.
  • Over the past 3 years, Aquestive Therapeutics' median Assets Average value was $59.5 million (recorded in 2022), while the average stood at $65.4 million.
  • In the last 5 years, Aquestive Therapeutics' Assets Average declined by 14.50% in 2020 and then spiked by 38.74% in 2024.
  • Over the past 5 years, Aquestive Therapeutics' Assets Average (Yearly) stood at $70.7 million in 2020, then dropped by 11.66% to $62.4 million in 2021, then decreased by 4.66% to $59.5 million in 2022, then dropped by 3.84% to $57.2 million in 2023, then spiked by 38.74% to $79.4 million in 2024.